BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9066005)

  • 21. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
    Henrion D; Dechaux E; Dowell FJ; Maclour J; Samuel JL; Lévy BI; Michel JB
    Br J Pharmacol; 1997 May; 121(1):83-90. PubMed ID: 9146891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular B1 kinin receptors in patients with congestive heart failure.
    Lang NN; Cruden NL; Tse GH; Bloomfield P; Ludlam CA; Fox KA; Newby DE
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):438-44. PubMed ID: 19033823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bradykinin receptor antagonism and endothelial tissue plasminogen activator release in humans.
    Witherow FN; Dawson P; Ludlam CA; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1667-70. PubMed ID: 12869356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of thiazide and thiazide-potassium sparing diuretics on fibrinolytic system parameters.
    Kaşifoğlu T; Yalçin AU
    Anadolu Kardiyol Derg; 2006 Jun; 6(2):143-7. PubMed ID: 16766279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A
    Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secretion of tissue plasminogen activator and plasminogen activator inhibitor 1 during cardiopulmonary bypass.
    Chandler WL; Velan T
    Thromb Res; 2003; 112(3):185-92. PubMed ID: 14967416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
    Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
    J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans.
    Chia S; Qadan M; Newton R; Ludlam CA; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):695-701. PubMed ID: 12692009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential control of MMP and t-PA/PAI-1 expressions by sympathetic and renin-angiotensin systems in rat left ventricle.
    Dab H; Hachani R; Hodroj W; Sakly M; Bricca G; Kacem K
    Auton Neurosci; 2009 Oct; 150(1-2):27-32. PubMed ID: 19403340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bradykinin decreases plasminogen activator inhibitor-1 expression and facilitates matrix degradation in the renal tubulointerstitium under angiotensin-converting enzyme blockade.
    Okada H; Watanabe Y; Kikuta T; Kobayashi T; Kanno Y; Sugaya T; Suzuki H
    J Am Soc Nephrol; 2004 Sep; 15(9):2404-13. PubMed ID: 15339989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function.
    Ridker PM; Gaboury CL; Conlin PR; Seely EW; Williams GH; Vaughan DE
    Circulation; 1993 Jun; 87(6):1969-73. PubMed ID: 8504511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a long-term pharmacological interruption of the renin-angiotensin system on the fibrinolytic system in essential hypertension.
    Sakata K; Pawlak R; Urano T; Takada A
    Pathophysiol Haemost Thromb; 2002; 32(2):67-75. PubMed ID: 12214151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension.
    Erdem Y; Usalan C; Haznedaroğlu IC; Altun B; Arici M; Yasavul U; Turgan C; Cağlar S
    Am J Hypertens; 1999 Nov; 12(11 Pt 1):1071-6. PubMed ID: 10604482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting enzyme inhibition augments coronary release of tissue plasminogen activator in women but not in men.
    Matsumoto T; Takashima H; Nakae I; Yamane T; Hayashi H; Horie M;
    Hypertension; 2010 Sep; 56(3):364-8. PubMed ID: 20606106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 17Beta-estradiol increases basal but not bradykinin-stimulated release of active t-PA in young postmenopausal women.
    Pretorius M; van Guilder GP; Guzman RJ; Luther JM; Brown NJ
    Hypertension; 2008 Apr; 51(4):1190-6. PubMed ID: 18259028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy.
    Witherow FN; Dawson P; Ludlam CA; Fox KA; Newby DE
    J Am Coll Cardiol; 2002 Sep; 40(5):961-6. PubMed ID: 12225723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous tissue plasminogen activator enhances fibrinolysis and limits thrombus formation in a clinical model of thrombosis.
    Lucking AJ; Gibson KR; Paterson EE; Faratian D; Ludlam CA; Boon NA; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2013 May; 33(5):1105-11. PubMed ID: 23471234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of yimai jiangya extract on platelet activation and fibrinolytic activity and angiotensin II in aged patients with essential hypertension].
    Duan X; Yang D; Sun X
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Jul; 20(7):508-10. PubMed ID: 11789207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute and chronic effects of oestrogen on endothelial tissue-type plasminogen activator release in postmenopausal women.
    Hoetzer GL; Stauffer BL; Irmiger HM; Ng M; Smith DT; DeSouza CA
    J Physiol; 2003 Sep; 551(Pt 2):721-8. PubMed ID: 12815179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.